FDA Approved: MEDROXYPROGESTERONE ACETATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Medroxyprogesterone Acetate submitted by Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Amenorrhea
• Contraception
• Endometriosis

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

SUPPL AP for MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)